Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis

NCT04749667 is registered in ClinicalTrials.gov with Haukeland University Hospital as lead sponsor.

NCT NCT04749667
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04749667 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis
Lead sponsor
Haukeland University Hospital
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
August 9, 2021
Completion date
March 15, 2027
Enrollment
18 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis, progressive multiple sclerosis